Association between BCL2 interacting protein 3 like (BNIP3L) genetic polymorphisms and the risk of multiple myeloma in China

References

• Rollig C, Knop S, Bornhauser M. Multiple myeloma. Lancet. 2015;385:2197–2208. doi:10.1016/S0140-6736(14)60493-1
   PubMed Web of Science ®Google Scholar
• Sonneveld P, Avet-Loiseau H, Lonial S, et al. Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group. Blood. 2016;127:2955–2962. doi:10.1182/blood-2016-01-631200
   PubMed Web of Science ®Google Scholar
• Wallington-Beddoe CT, Mynott RL. Prognostic and predictive biomarker developments in multiple myeloma. J Hematol Oncol. 2021;14:151, doi:10.1186/s13045-021-01162-7
   PubMed Web of Science ®Google Scholar
• Gozzetti A, Ciofini S, Simoncelli M, et al. Anti CD38 monoclonal antibodies for multiple myeloma treatment. Hum Vaccin Immunother. 2022;18:2052658, doi:10.1080/21645515.2022.2052658
   PubMed Web of Science ®Google Scholar
• Guzdar A, Costello C. Supportive care in multiple myeloma. Curr Hematol Malig Rep. 2020;15:56–61. doi:10.1007/s11899-020-00570-9
   PubMed Web of Science ®Google Scholar
• Mailankody S, Devlin SM, Landa J, et al. GPRC5D-Targeted CAR T cells for myeloma. N Engl J Med. 2022;387:1196–1206. doi:10.1056/NEJMoa2209900
   PubMed Web of Science ®Google Scholar
• Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 2009;16:939–946. doi:10.1038/cdd.2009.16
   PubMed Web of Science ®Google Scholar
• Ruolin L, Chen G, Dang Y, et al. Expression and clinical significance of BCL2 interacting protein 3 like in multiple myeloma. Technol Cancer Res Treat. 2021;20:15330338211024551.
   Web of Science ®Google Scholar
• Zhou J, Ma C, Wang K, et al. Identification of rare and common variants in BNIP3L: a schizophrenia susceptibility gene. Hum Genomics. 2020;14:16, doi:10.1186/s40246-020-00266-4
   PubMed Web of Science ®Google Scholar
• Li R, Hu Z, Chen H, et al. Association of growth differentiation factor-15 polymorphisms and growth differentiation factor-15 serum levels with susceptibility to multiple myeloma in a Chinese population. Clin Lab. 2021;6(1). doi:10.7754/Clin.Lab.2020.200341
   Google Scholar
• [Guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)]. Zhonghua Nei Ke Za Zhi. 2022;61:480–487.
   PubMedGoogle Scholar
• Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97–98. doi:10.1038/sj.cr.7290272
   PubMed Web of Science ®Google Scholar
• Manunta P, Tripodi G. Haplotype analysis in human hypertension. J Hypertens. 2005;23:711–712. doi:10.1097/01.hjh.0000163135.69643.e4
   PubMed Web of Science ®Google Scholar
• Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science. 1997;278:1580–1581. doi:10.1126/science.278.5343.1580
   PubMed Web of Science ®Google Scholar
• Imazu T, Shimizu S, Tagami S, et al. Bcl-2/E1B 19 kDa-interacting protein 3-like protein (Bnip3L) interacts with Bcl-2/Bcl-xL and induces apoptosis by altering mitochondrial membrane permeability. Oncogene. 1999;18:4523–4529. doi:10.1038/sj.onc.1202722
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zheng Y, Zhang X, et al. BNIP3L/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2. Autophagy. 2017;13:1754–1766. doi:10.1080/15548627.2017.1357792.
   PubMed Web of Science ®Google Scholar
• O'Sullivan TE, Johnson LR, Kang HH, et al. BNIP3- and BNIP3L-mediated mitophagy promotes the generation of natural killer cell memory. Immunity. 2015;43:331–342. doi:10.1016/j.immuni.2015.07.012
   PubMed Web of Science ®Google Scholar
• Xu D, Chen P, Wang B, et al. NIX-mediated mitophagy protects against proteinuria-induced tubular cell apoptosis and renal injury. Am J Physiol Renal Physiol. 2019;316:F382–F395. doi:10.1152/ajprenal.00360.2018.
   PubMed Web of Science ®Google Scholar
• da Silva Rosa SC, Martens MD, Field JT, et al. BNIP3L/Nix-induced mitochondrial fission, mitophagy, and impaired myocyte glucose uptake are abrogated by PRKA/PKA phosphorylation. Autophagy. 2021;17:2257–2272. doi:10.1080/15548627.2020.1821548
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng W, Lu Y, et al. BNIP3L/NIX-mediated mitophagy: molecular mechanisms and implications for human disease. Cell Death Dis. 2022;13:14. doi:10.1038/s41419-021-04469-y
   Web of Science ®Google Scholar
• Panigrahi DP, Praharaj PP, Bhol CS, et al. The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics. Semin Cancer Biol. 2020;66:45–58. doi:10.1016/j.semcancer.2019.07.015
   PubMed Web of Science ®Google Scholar
• Schweers RL, Zhang J, Randall MS, et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc Natl Acad Sci USA. 2007;104:19500–19505. doi:10.1073/pnas.0708818104
   PubMed Web of Science ®Google Scholar
• Sandoval H, Thiagarajan P, Dasgupta SK, et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature. 2008;454:232–235. doi:10.1038/nature07006
   PubMed Web of Science ®Google Scholar
• Chourasia AH, Boland ML, Macleod KF. Mitophagy and cancer. Cancer Metab. 2015;3:4, doi:10.1186/s40170-015-0130-8
   PubMed Web of Science ®Google Scholar
• Drake LE, Springer MZ, Poole LP, et al. Expanding perspectives on the significance of mitophagy in cancer. Semin Cancer Biol. 2017;47:110–124. doi:10.1016/j.semcancer.2017.04.008
   PubMed Web of Science ®Google Scholar
• Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148:1145–1159. doi:10.1016/j.cell.2012.02.035
   PubMed Web of Science ®Google Scholar
• Lazarini M, Machado-Neto JA, Duarte AD, et al. BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine. Haematologica. 2016;101:e445–e448. doi:10.3324/haematol.2016.142521
   PubMed Web of Science ®Google Scholar
• Jung J, Zhang Y, Celiku O, et al. Mitochondrial NIX promotes tumor survival in the hypoxic niche of glioblastoma. Cancer Res. 2019;79:5218–5232. doi:10.1158/0008-5472.CAN-19-0198
   PubMed Web of Science ®Google Scholar
• Humpton TJ, Alagesan B, DeNicola GM, et al. Oncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer. Cancer Discov. 2019;9:1268–1287. doi:10.1158/2159-8290.CD-18-1409
   PubMed Web of Science ®Google Scholar
• Sun JL, He XS, Yu YH, et al. Expression and structure of BNIP3L in lung cancer. Ai Zheng. 2004;23:8–14.
   PubMedGoogle Scholar
• Wang WJ, Wang Y, Chen HZ, et al. Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway. Nat Chem Biol. 2014;10:133–140. doi:10.1038/nchembio.1406
   PubMed Web of Science ®Google Scholar
• Gallegos ZR, Taus P, Gibbs ZA, et al. EWSR1-FLI1 activation of the cancer/testis antigen FATE1 promotes ewing sarcoma survival. Mol Cell Biol. 2019:39(14):e00138-19. doi:10.1128/MCB.00138-19
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Mendis N, Ibrahim M, et al. Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs. Autophagy. 2019;15:900–907. doi:10.1080/15548627.2018.1558002
   PubMed Web of Science ®Google Scholar
• Liu X, Zhou Z, Sun D. Values of immunoglobulin and complements for evaluating treatment outcomes of patients with multiple myeloma. Clin Lab. 2023:69(11). doi:10.7754/Clin.Lab.2023.230210
   Web of Science ®Google Scholar
• Guo S, Zhi Y, Yang H, et al. Bcl-2 expression is associated with poor prognosis of solitary plasmacytoma of bone. Ann Hematol. 2014;93:471–477. doi:10.1007/s00277-013-1897-8
   PubMed Web of Science ®Google Scholar